The bill establishes a Cancer Clinical Trial Participation Program in Texas, aimed at increasing participation in cancer clinical trials by providing financial support for ancillary costs incurred by participants. It recognizes that financial barriers, such as transportation and lodging expenses, disproportionately affect individuals from lower-income households, thereby limiting their participation in clinical trials. The program will be developed and implemented by public or private institutions of higher education, independent research organizations, or independent third-party organizations, which will provide reimbursement for costs including travel, lodging, meals, and childcare.

Key provisions of the bill include the requirement for the program to notify prospective subjects about available financial support when they provide informed consent for a clinical trial. It also stipulates that reimbursements must be based on financial need and comply with federal and state laws. Importantly, the bill clarifies that reimbursement for ancillary costs does not constitute an inducement to participate in a trial, aiming to eliminate misconceptions about financial support in clinical research. The program may accept funding from various sources to facilitate its implementation and may collaborate with the Cancer Prevention and Research Institute of Texas.

Statutes affected:
Introduced: ()